XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity (Details) - USD ($)
 1 Months Ended 12 Months Ended
Dec. 09, 2021
Oct. 01, 2021
Jul. 12, 2021
Jan. 06, 2021
Dec. 16, 2020
May 15, 2020
Apr. 27, 2020
Apr. 01, 2020
Dec. 31, 2021
Dec. 22, 2021
Dec. 17, 2021
Sep. 30, 2021
Jul. 16, 2021
Jun. 25, 2021
Jun. 18, 2021
Feb. 18, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 08, 2021
May 31, 2021
Dec. 31, 2014
Stockholders' Equity (Details) [Line Items]                                          
Common stock issued (in Shares)                                 0 42,475      
Shares issued for cashless exercise of warrants (in Shares)                 0               0 60,513      
Exercise of warrants (in Dollars)                                 $ 2,628,061 $ 8,056,416      
Shares of common stock (in Shares)                 0               0 90,204 8,823,530    
Issued of common stock (in Shares)                 27,740,147               27,740,147 16,332,939      
Net cash proceeds (in Dollars)                                 $ 161,226,945        
Common stock, par value (in Dollars per share)                 $ 0.001               $ 0.001 $ 0.001 $ 0.001    
Price per share (in Dollars per share)                                     17    
Underwriters granted period 30 days                                        
Additional shares of common stock (in Shares) 1,323,529                                        
Granting of common stock awards (in Shares)                                         5,152,942
Granting to option or stock awards (in Dollars)                 $ 6,652,942               $ 6,652,942     $ 1,500,000  
Stock options exercisable period                                 10 years        
Vesting period                                 4 years        
Issued shares (in Shares)                                 3,900,000        
Options for shares (in Shares)                                 3,821,118        
Options awarded (in Shares)                   65,000                      
Exercise price (in Dollars per share)                   $ 21.11                      
Term                   10 years                      
Expected life term                                   6 years 3 months      
Expected dividends rate                                 0.00% 0.00%      
Shareholder approval shares (in Shares)                     3,821,118                    
Stock options, description                       As of December 31, 2021, six performance metrics for 520,000 options were met. Vesting of such options is subject to the passage of time. At December 31, 2021, the Company incurred expense of $3,392,419 related to these options.During the year ended December 31, 2020, the Company awarded a total of 1,000,000 options to employees with exercise prices ranging from $28.00- $45.61 and a 10-year term vesting over 4-year period. The options have an aggregate fair value of $32.4 million calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.36%-0.83% (2) expected life of 6.25 years, (3) expected volatility of 101%-108%, and (4) zero expected dividends. During the year ended December 31, 2020, the Company recognized additional compensation expense of approximately $1,500,000 related to acceleration of vesting and a nominal amount related to the modification of certain options in connection with the separation and settlement agreement with Dr. Ottavio Vitolo (see note 10). During the year ended December 31, 2020, the Company recognized compensation expense of approximately $484,000 related to the extended period of time to allow for some options to vest under the separation and settlement agreement with Dr. Thomas Wessel. This was considered a Type III modification and as a result the total expense of $1.8 million previously recognized was reversed as the options would not have vested prior to the modification (see note 10). A summary of the changes in options outstanding for the years ended December 31, 2021 and 2020 is as follows:     Number of Shares   Weighted Average Exercise Price Per Share   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value  Outstanding and expected to vest at December 31, 2019   3,615,602   $19.96    9.2   $74,837,043  Granted   1,000,000    39.50    9.3    -  Exercised   (253,927)   -    -    -  Forfeited   (455,938)   -    -    -  Outstanding and expected to vest at December 31, 2020   3,905,737   $24.32    8.4   $48,952,339  Granted   7,057,004    21.15    9.8    -  Exercised   (174,619)   -    -    -  Forfeited   (457,500)   -    -    -  Outstanding and expected to vest at December 31, 2021   10,330,622   $22.52    9.0   $46,088,534  Options exercisable at December 31, 2021   2,140,490   $20.99    7.3   $19,511,463   At December 31, 2021, the Company has unrecognized stock-based compensation expense of approximately $143,200,000 related to unvested stock options over the weighted average remaining service period of 2.94 years. The weighted average fair value of options granted during the years ended December 31, 2021 and 2020 was approximately $22.15 and $32.45 per share, respectively, on the date of grant using the Black-Scholes option pricing model with the following assumptions:      Years Ended   Years Ended     December 31,   December 31,     2021   2020  Risk free interest rate  0.59 to 1.31%  0.36 to 0.83% Dividend yield   0%   0% Volatility     97-101 %     101-108% Expected term (in years)     5 to 6.25      6.25    Warrants A summary of the changes in outstanding warrants during the years ended December 31, 2021 and 2020 is as follows:      Number of Shares   Weighted Average Exercise Price Per Share  Outstanding at December 31, 2019   3,646,870   $6.83  Issued   250,000   $33.32  Exercised   (1,211,199)  $7.27  Forfeited/Expired   (15,040)  $16.80  Outstanding at December 31, 2020   2,670,633   $9.11  Issued   972,000   $31.98  Exercised   (433,856)  $6.06  Outstanding at December 31, 2021   3,208,777   $16.45  Warrants exercisable at December 31, 2021   2,767,246   $13.92   On October 1, 2021, the Company awarded a total of 42,000 warrants to a consultant with an exercise price of $26.74 and a 10-year term, vesting 25% after year one and 6.25% quarterly there after until 100% vested. The warrants have an aggregate fair value of $891,265 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 1.10% (2) expected life of 6.25 years, (3) expected volatility of 99%, and (4) zero expected dividends. On July 16, 2021, the Company awarded a total of 500,000 warrants to Arbormentis, LLC with an exercise price of $31.17 and a 7-year term, vesting immediately. The warrants have an aggregate fair value of $10,241,599 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.48% (2) expected life of 3.50 years, (3) expected volatility of 101%, and (4) zero expected dividends. On July 12, 2021, the Company awarded a total of 10,000 warrants to a consultant with an exercise price of $34.77 and a 5-year term, vesting over a 1-year period. The warrants granted are time-based vesting. The warrants have an aggregate fair value of $212,219 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.43% (2) expected life of 3.00 years, (3) expected volatility of 99%, and (4) zero expected dividends. On June 25, 2021, the Company awarded a total of 10,000 warrants to a consultant with an exercise price of $34.35 and a 5-year term, vesting over a 1-year period. The warrants granted are time-based vesting. The warrants have an aggregate fair value of $211,653 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.43% (2) expected life of 3.00 years, (3) expected volatility of 100%, and (4) zero expected dividends. On June 18, 2021, the Company awarded a total of 10,000 warrants to a consultant with an exercise price of $30.90 and a 5-year term, vesting over a 1-year period. The warrants granted are time-based vesting. The warrants have an aggregate fair value of $190,401 calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.47% (2) expected life of 3.00 years, (3) expected volatility of 100%, and (4) zero expected dividends. On January 6, 2021, the Company awarded a total of 400,000 warrants to consultants with an exercise price of $33.43 and a 10-year term, vesting over 4-year period. The warrants granted include time-based vesting grants and performance vesting based on the Company’s achievement of performance metrics. The warrants have an aggregate fair value of $10.6 million calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.59% (2) expected life of 6.25 years, (3) expected volatility of 101%, and (4) zero expected dividends. As of December 31, 2021, six performance metrics for 200,000 warrants were met. Vesting of such options is subject to the passage of time.                  
Description of employees options                                   The options have an aggregate fair value of $32.4 million calculated using the Black-Scholes option-pricing model. Variables used in the Black-Scholes option-pricing model include: (1) discount rate of 0.36%-0.83% (2) expected life of 6.25 years, (3) expected volatility of 101%-108%, and (4) zero expected dividends.      
Additional compensation expense (in Dollars)                                 $ 40,494,476 $ 20,777,272      
Recognized compensation expense (in Dollars)                                   484,000      
Total expense (in Dollars)                                   $ 1,800,000      
Unrecognized stock-based compensation expense (in Dollars)                 $ 12,400,000               $ 12,400,000        
Weighted average remaining service period                                 2 years 11 months 8 days        
Number of granted warrants (in Shares)                                 7,057,004 1,000,000      
Performance metrics, description                 As of December 31, 2021, six performance metrics for 200,000 warrants were met.                        
Incurred expense (in Dollars)                 $ 1,304,776               $ 1,304,776        
Aggregate intrinsic value of warrants vested and outstanding (in Dollars)                 31,300,000               31,300,000        
Stock Based Compensation [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Additional compensation expense (in Dollars)                                   $ 1,500,000      
Unrecognized stock-based compensation expense (in Dollars)                 $ 143,200,000               $ 143,200,000        
Jefferies LLC [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Aggregate of offering price (in Dollars)           $ 75,000,000                              
Black-Scholes Option Pricing Model [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Aggregate fair value of options (in Dollars)       $ 39,700,000           $ 1,100,000           $ 701,000          
Discount rate       0.59%                       0.75%          
Expected life term       6 years 3 months                       6 years 3 months          
Expected volatility rate       101.00%                       101.00%          
Expected dividends rate       0.00%           0.00%           0.00%          
Consultants [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Aggregate fair value of options (in Dollars)   $ 891,265 $ 212,219 $ 10,600,000 $ 2,860,000     $ 2,500,000           $ 211,653 $ 190,401            
Discount rate   1.10% 0.43% 0.59% 0.37%     0.26%           0.43% 0.47%            
Expected life term   6 years 3 months 3 years 6 years 3 months 5 years     2 years 6 months           3 years 3 years            
Expected volatility rate   99.00% 99.00% 101.00% 105.00%     118.00%           100.00% 100.00%            
Expected dividends rate   0.00% 0.00% 0.00% 0.00%     0.00%           0.00% 0.00%            
Number of granted warrants (in Shares)   42,000 10,000 400,000 108,000     120,000           10,000 10,000            
Exercise price per share (in Dollars per share)   $ 26.74 $ 34.77 $ 33.43 $ 34.87     $ 31.59           $ 34.35 $ 30.9            
Term year   10 years 5 years 10 years 5 years     5 years           5 years 5 years            
Vesting period     1 year 4 years                   1 year 1 year            
Arbormentis, LLC [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Aggregate fair value of options (in Dollars)                         $ 10,241,599                
Discount rate                         0.48%                
Expected life term                         3 years 6 months                
Expected volatility rate                         101.00%                
Expected dividends rate                         0.00%                
Number of granted warrants (in Shares)                         500,000                
Exercise price per share (in Dollars per share)                         $ 31.17                
Term year                         7 years                
Consultant One [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Aggregate fair value of options (in Dollars)         $ 479,000   $ 48,000                            
Discount rate         0.37%   0.27%                            
Expected life term         3 years 9 months   2 years 6 months                            
Expected volatility rate         105.00%   116.00%                            
Expected dividends rate         0.00%   0.00%                            
Number of granted warrants (in Shares)         20,000   2,000                            
Exercise price per share (in Dollars per share)         $ 34.87   $ 37.67                            
Term year         5 years   5 years                            
Vesting period         4 years                                
Underwriters [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Price per share (in Dollars per share)                                     $ 15.98    
Stock Options [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Vesting period       4 years                       4 years          
Options awarded (in Shares)       1,490,000                       25,000          
Exercise price (in Dollars per share)       $ 33.43                       $ 35.15          
Term       10 years                       10 years          
Vesting Period Four [Member] | Black-Scholes Option Pricing Model [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Expected dividends rate                     0.00%                    
Minimum [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Vesting period                   1 year                      
Discount rate                                 0.59% 0.36%      
Expected life term                                 5 years        
Expected volatility rate                                 97.00% 101.00%      
Minimum [Member] | Black-Scholes Option Pricing Model [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Discount rate                   1.23%                      
Expected life term                   5 years 6 months                      
Expected volatility rate                   96.00%                      
Minimum [Member] | Vesting Period One to Four [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Expected life term                     5 years 2 months 12 days                    
Expected volatility rate                     97.00%                    
Minimum [Member] | Vesting Period One to Four [Member] | Black-Scholes Option Pricing Model [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Discount rate                     1.18%                    
Maximum [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Vesting period                   4 years                      
Discount rate                                 1.31% 0.83%      
Expected life term                                 6 years 3 months        
Expected volatility rate                                 101.00% 108.00%      
Maximum [Member] | Black-Scholes Option Pricing Model [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Discount rate                   1.31%                      
Expected life term                   6 years 3 months                      
Expected volatility rate                   98.00%                      
Maximum [Member] | Vesting Period One to Four [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Vesting period                     1 year                    
Expected life term                     5 years                    
Maximum [Member] | Vesting Period One to Four [Member] | Black-Scholes Option Pricing Model [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Aggregate fair value of options (in Dollars)                     $ 81.6                    
Discount rate                     1.26%                    
Expected volatility rate                     99.00%                    
Maximum [Member] | Vesting Period One to Four [Member] | Stock Options [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Vesting period                     4 years                    
Options awarded (in Shares)                     5,477,004                    
Exercise price (in Dollars per share)                     $ 19.03                    
Term                     10 years                    
Common Stock [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Common stock issued (in Shares)                                 433,856 1,159,989      
Shares of common stock (in Shares)                 174,619               174,619 155,558      
Issued of common stock (in Shares)                 0               0 98,370      
Exercised common shares issued (in Shares)                                 668,431 735,514      
Additional compensation expense (in Dollars)                                      
Common Stock [Member] | Jefferies LLC [Member]                                          
Stockholders' Equity (Details) [Line Items]                                          
Shares of common stock (in Shares)                 651,674               651,674 427,700      
Net cash proceeds (in Dollars)                                 $ 23,416,036 $ 19,791,644